The store will not work correctly when cookies are disabled.
5-(4-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA78668
PubChem CID: 10265702
Max Phase: Preclinical
Molecular Formula: C17H13ClN2
Molecular Weight: 280.76
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc(C2=Cc3ccccc3C3=NCCN23)cc1
Standard InChI: InChI=1S/C17H13ClN2/c18-14-7-5-12(6-8-14)16-11-13-3-1-2-4-15(13)17-19-9-10-20(16)17/h1-8,11H,9-10H2
Standard InChI Key: KNRZKSWPBFNURY-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
6.8917 -2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3792 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9292 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4167 -1.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8667 -2.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3792 -2.9667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8792 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8250 -1.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8167 -0.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4167 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4167 -2.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7167 -1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4167 -0.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4250 -1.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3167 -1.4750 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.3292 -2.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3667 -1.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8167 -2.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8375 -1.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 8 2 0
10 8 1 0
11 1 1 0
12 11 1 0
13 14 1 0
14 10 2 0
15 9 1 0
16 13 1 0
17 5 1 0
18 7 1 0
19 17 2 0
20 18 2 0
6 12 1 0
5 7 2 0
15 13 2 0
20 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.76 | Molecular Weight (Monoisotopic): 280.0767 | AlogP: 3.91 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.13 | CX LogP: 3.66 | CX LogD: 3.48 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -0.50 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |